Clinical Trial Update: Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia [Phase 3]

View source ↗

Summary

A Phase 3 interventional trial evaluating Vosoritide for hypochondroplasia in children is active but not recruiting. This document updates the status of the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypochondroplasia

Drugs mentioned

• Vosoritide (vosoritide)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Hypochondroplasia | Phase 3 | Status: ACTIVE_NOT_RECRUITING